Atlanta-based Piedmont Healthcare participates in the U.S. Food and Drug Administration’s (FDA) expanded access progress for the antiviral drug remdesivir, which was recently granted emergency use authorization (EUA) on May 1. The investigational drug evidenced in a clinical trial that it could compress the average COVID-19 recovery time from 15 days down to 11 days.
Piedmont Sites on the ‘Front Lines of COVID-19 Pandemic
This program is available for patients at Piedmont Atlanta Hospita, Piedmont Fayette Hospital and Piedmont Columbus Regional-Midtown Campus and could be expanded to other Piedmont Hospitals. Piedmont has previously participated in the FDA’s compassionate use program for remdesivir.
Charles L. Brown, III, MD, CEO of Piedmont Healthcare’s Physician Enterprise, commented recently that “Piedmont’s providers have been on the front lines of the COVID-19 pandemic and remdesivir gives them another tool to help our patients.”
Principal Investigators for Remdesivir Use at Piedmont
Amy Hajari Case, MD, is Piedmont’s Medical Director of Pulmonary and Critical Care Research and principal investigator for this program at Piedmont Atlanta. Ameera Waseem Siddiqi, MD, is the investigator at Piedmont Fayette and Saeed Aasim Baloch, MD, is the investigator at Piedmont Columbus.
Dr. Case reported that Piedmont is on a mission to help patients, noting on the investigational drug, “We had a positive experience with remdesivir early in the pandemic and are excited to be able to provide to our patients again.”
Amy Hajari Case, MD, Piedmont’s Medical Director of Pulmonary and Critical Care Research and principal investigator
Ameera Waseem Siddiqi, MD, investigator at Piedmont Fayette
Saeed Aasim Baloch, MD, investigator at Piedmont Columbus
About Piedmont Healthcare
Piedmont Healthcare has been active for over a century as a leader in delivering expert care. They served nearly two million patients last year: performing over 44,000 surgeries and delivering 8,000 babies and providing 471,695 outpatient encounters; 235 organ transplants and 250,000 emergency room visits.
Working for Health Equity
Piedmont Healthcare’s Dr. Jayne Morgan was interviewed on the TrialSite News Podcast series about the inequities and obstacles involved with including minorities in clinical trials. Dr. Morgan is very active in the cardiovascular research space in the Atlanta area where she works to involve more African Americans. Piedmont gets ranked under TrialSite News’ ‘Site Watch Leading’ category.
Call to Action: If you or a loved one know of someone in Atlanta or other areas where Piedmont is located, that could benefit from this study see the link to the study information.Source: